Skip to content

Clinical trials

Completed Phase 3 Myocardial Infarction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Status: Completed Clear all

132 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20014
20024
20037
20045
20059
20068
20072
20087
20092
20106
20115
20124
20135
20146
20154
20163
20173
20183
20191
20202
20215
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed132

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)20
Boehringer Ingelheim6
Assistance Publique - Hôpitaux de Paris4
AstraZeneca3
Brigham and Women's Hospital3
GlaxoSmithKline3
Rutgers, The State University of New Jersey3
Sanofi3
Stiftung Institut fuer Herzinfarktforschung3
University of Washington3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction132
Cardiovascular Diseases42
Heart Diseases35
Myocardial Ischemia31
Coronary Disease26
Acute Coronary Syndrome20
Stroke19
Angina, Unstable17
Heart Failure15
ST Elevation Myocardial Infarction13

Trials

Showing 1 to 25 of 132. Each trial links to its page on Pharma Observatory.

32 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.